对多发性硬化症患者抑郁症状的干预措施的有效性,安全性和耐受性进行比较:系统性审查
Stephanie Campese1, Julia Lyons2, Yvonne C Learmonth3
1Disability and Health Unit, The Melbourne School of Population and Global Health, The University of Melbourne, Victoria, Australia.
Multiple sclerosis and related disorders
|July 20, 2024
概括
目前,治疗多发性硬化症 (MS) 抑郁症的证据较少. 迫切需要高质量的试验来比较MS相关抑郁症状的不同干预措施的有效性和安全性.
科学领域:
- 神经科学是一个神经科学.
- 临床心理学 临床心理学
- 康复医学 康复医学 康复医学
背景情况:
- 抑郁症是多发性硬化症 (MS) 的常见并发症,严重影响患者的生活质量.
- 现有的针对多发性硬化症抑郁症状的干预措施缺乏比较有效性的数据.
- 本系统性审查评估了MS患者抑郁症各种治疗方式的疗效,安全性和耐受性.
结论:
- 目前治疗多发性硬化症抑郁症的证据基础质量不佳,因此无法在干预模式之间进行可靠的比较.
- 需要高质量,多样化的RCT来调查和比较MS患者抑郁症的治疗选择.
- 改善RCT的行为和报告标准对于产生可靠的临床实践证据至关重要.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
209
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
209
Depressive Disorders: MDD and Dysthymia
90
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
90
Depression: Overview
231
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
231
Electroconvulsive Therapy
30
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
30


